06/12/2018 16:48:44

INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tesaro, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, Dec. 06, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Tesaro, Inc. (“Tesaro” or “the Company”) (NASDAQ: TSRO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's shares between November 4, 2016 and November 14, 2016, inclusive (the ''Class Period''), are encouraged to contact the firm before January 9, 2019.                                   

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Tesaro’s liquid assets were not sufficient to fund operations and meet all cash flow requirements, despite completing a public offering of stock in early July, 2016. As a result of this liquidity shortfall, the Company planned another offering of stock just four months later. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Tesaro, investors suffered damages.

Join the case

to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm

Brian Schall, Esq.,

Sherin Mahdavian, Esq.,

www.schallfirm.com

310-301-3335

info@schallfirm.com

SOURCE:

 The Schall Law Firm

Schall Firm Logo 2.jpg

Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
19 Mar
I:SP500
Hejsa Lidt forårs opdatering. Langsigtet konjunkturmodel: Nederst kan I se den langsigtede konjunktu..
71
25 Mar
BAVA
En ting er, at du sylter os ind i dit misforståede bavl om BAVA. Det er, hvad det er.    Noget andet..
15
23 Mar
 
Hej Kanonkugle   Der er endnu ikke inversrentekurve i USA, det måles som forskellen mellem den 2 og ..
15
19 Mar
VELO
  Studiet er et randomiseret fase 4 forsøg, hvor man sammenligner forlænget frigivelse Envarsus XR (..
14
23 Mar
CHEMM
Chemometec er ikke i nedtrend som helhed. Aktien har haft en foreløbig top. Har fundet en bund som e..
12
21 Mar
BAVA
Jeg synes bestemt også der skal være plads til kritikere af Bavarian. Der skal være plads til alle i..
12
21 Mar
PNDORA
Du rammer jo netop ned i strategien "NOW", hvor der kigges ind i hvilke butikker der er lønsomme. Sa..
12
20 Mar
ZEAL
Jeg skrev til IR vedr. lidt forskelligt, her er deres svar:  Bliver der afholdt en Capital Market D..
12
25 Mar
 
Jeg tror ikke Theresa May overlever dette inferno, hun selv har en stor del af ansvaret for. Det ene..
11
21 Mar
I:SP500
Der er en alt afgørende ting som Rangvid ikke tager højde for, og som Lars Christensen glemmer at kr..
11

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
UKTW I²P Celebrates First Successful Year of UK-TW Science Research Cooperation
2
ExCellThera announces clearance by FDA and Health Canada for ECT-001 in new clinical trials in United States and Canada for the treatment of leukemia
3
Reminder - Product Tanker, Crude Oil Tanker, LNG, LPG and Chemical Tankers Sector Panel Discussions With Major Shipping Company Executives
4
Invitation by Aperam S.A. to holders of its outstanding U.S.$300,000,000 0.625 per cent. Net Share Settled Convertible and/or Exchangeable Bonds due 2021 (ISIN XS1084287322) (the “Bonds”) convertible into common shares of Aperam S.A. to off
5
Philips expands its radiology solutions offering with advanced teleradiology services

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
26 March 2019 03:06:15
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190320.1 - EUROWEB4 - 2019-03-26 04:06:15 - 2019-03-26 03:06:15 - 1000 - Website: OKAY